Resected pancreatic adenocarcinoma: An Asian institution's experience

Resected pancreatic adenocarcinoma: An Asian institution's experience

Abstract Background Pancreatic adenocarcinoma (PDAC) is highly lethal. Surgery offers the only chance of cure, but 5‐year overall survival (OS) after surgical resection and adjuvant therapy remains dismal. Adjuvant trials were mostly conducted in the West enrolling fit patients. Applicability to a g...

Full description

Bibliographic Details
Main Authors: Kennedy Yao Yi Ng, Edwin Wei Xiang Chow, Bochao Jiang, Cindy Lim, Brian Kim Poh Goh, Ser Yee Lee, Jin Yao Teo, Damien Meng Yew Tan, Peng Chung Cheow, London Lucien Peng Jin Ooi, Pierce Kah Hoe Chow, Joycelyn Jie Xin Lee, Juinn Huar Kam, Ye Xin Koh, Prema Raj Jeyaraj, Ek Khoon Tan, Su Pin Choo, Chung Yip Chan, Alexander Yaw Fui Chung, David Tai
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Cancer Reports
Subjects:
pancreatic adenocarcinoma
prognostic factors
resected
Online Access:https://doi.org/10.1002/cnr2.1393

Internet

https://doi.org/10.1002/cnr2.1393

Similar Items